EXCLUSIVE Exclusive Interview with PharmaShots: Nikhil Lalwani of ANI Pharmaceuticals Shares Insight on Purified Cortrophin GelBySenior EditorFebruary 21, 20220Comments
INSIGHTS+ Insights+: The US FDA New Drug Approvals in January 2022BySenior EditorFebruary 17, 20220Comments
VIEWPOINTS PharmaShots Interview: PolyPid’s Dikla Czaczkes Akselbrad Shares Insights on the P-III (SHIELD I) Trial of D-PLEX100BySenior EditorFebruary 16, 20220Comments
VIEWPOINTS PharmaShots Interview: 180 Life Sciences’ Dr. Jim Woody Shares Insight on Repurposing Anti-TNF to Meet Unmet Needs in Pain and InflammationBySenior EditorFebruary 15, 20220Comments
EXCLUSIVE Exclusive Interview with PharmaShots: John Meduri of Accelerate Diagnostics Shares Insight on Antimicrobial Resistance or AMRBySenior EditorFebruary 14, 20220Comments
VIEWPOINTS PharmaShots Interview: Myriad Genetics’ Todd Cohen Shares Insights on the Trends in Prostate Cancer and Precision MedicineBySenior EditorFebruary 9, 20220Comments
VIEWPOINTS PharmaShots Interview: Dermavant’s Philip M. Brown Shares Insights on the Clinical Data of Tapinarof Published in NEJMBySenior EditorFebruary 8, 20220Comments
EXCLUSIVE Exclusive Interview with PharmaShots: Moshe Safran of RSIP Vision Share Insight on the 3D Reconstruction TechnologyBySenior EditorFebruary 7, 20220Comments
